Detalhe da pesquisa
1.
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
N Engl J Med
; 390(4): 301-313, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38084760
2.
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.
N Engl J Med
; 389(4): 335-347, 2023 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272512
3.
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Blood
; 143(17): 1713-1725, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194692
4.
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma.
Lancet Oncol
; 25(5): e205-e216, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697166
5.
Single-cell analysis of the CD8+ T-cell compartment in multiple myeloma reveals disease specific changes are chiefly restricted to a CD69- subset suggesting potent cytotoxic effectors exist within the tumor bed.
Haematologica
; 109(4): 1220-1232, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794800
6.
Pregnancy and assisted reproductive technology use in Australian female transfusion-dependent haemoglobinopathy patients: a 20-year retrospective analysis.
Intern Med J
; 54(2): 290-294, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37449655
7.
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group.
Lancet Oncol
; 24(7): e293-e311, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414019
8.
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent ß-Thalassemia.
N Engl J Med
; 382(13): 1219-1231, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32212518
9.
The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia.
Intern Med J
; 53(5): 819-824, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880355
10.
Sickle cell disease in Australia: a snapshot from the Australian Haemoglobinopathy Registry.
Intern Med J
; 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38064543
11.
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
Br J Haematol
; 198(5): 830-837, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35818641
12.
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 380(1): 45-56, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501490
13.
The role of E3 ubiquitin ligase in multiple myeloma: potential for cereblon E3 ligase modulators in the treatment of relapsed/refractory disease.
Expert Rev Proteomics
; 19(4-6): 235-246, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342226
14.
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 22(10): 1403-1415, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516954
15.
Gene Therapy in Patients with Transfusion-Dependent ß-Thalassemia.
N Engl J Med
; 378(16): 1479-1493, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669226
16.
COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.
Intern Med J
; 51(5): 763-768, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047035
17.
Successful kidney transplantation in a patient with stable multiple myeloma.
Intern Med J
; 50(4): 492-494, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32270609
18.
The second revision of the International Staging System (R2-ISS) stratifies progression-free and overall survival in multiple myeloma: Real world data results in an Australian and New Zealand Population.
Br J Haematol
; 200(2): e17-e21, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36321478
19.
Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.
Haematologica
; 103(12): 2088-2096, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30237262
20.
Benign clinical phenotype of co-inherited congenital dyserythropoietic anaemia type I and heterozygous haemoglobin Lepore.
Eur J Haematol
; 111(1): 161-164, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37037770